Medicine and Dentistry
Airflow
11%
Bronchodilating Agent
11%
Chemotherapeutic Agent
11%
Chronic Obstructive Pulmonary Disease
66%
Development
11%
Disease Exacerbation
11%
Drug
11%
Drug Therapy
22%
Dry Powder Inhaler
11%
Endurance Training
11%
Evaluation Study
11%
Health
11%
Hyperinflation
11%
Inhalation
22%
Inpatient
11%
Lung
22%
Maintenance Therapy
11%
Monotherapy
11%
Muscarinic Antagonist
33%
Olodaterol
11%
Quality of Life
11%
Therapeutic Procedure
11%
Tiotropium Bromide
100%
Treatment of Chronic Obstructive Pulmonary Disease
22%
Pharmacology, Toxicology and Pharmaceutical Science
Aerosol
11%
Agonist
22%
Bronchodilating Agent
11%
Chronic Obstructive Lung Disease
66%
Controlled Clinical Trial
22%
Disease Exacerbation
11%
Drug
11%
Dry Powder Inhaler
11%
Dyspnea
11%
Monotherapy
11%
Muscarinic Receptor Blocking Agent
33%
Olodaterol
11%
Placebo
22%
Tiotropium Bromide
11%